TerminatedNCT02928510

Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma

Studying Indolent B-cell non-Hodgkin lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Jonsson Comprehensive Cancer Center
Principal Investigator
Daniel Hommes
UCLA / Jonsson Comprehensive Cancer Center
Intervention
Biospecimen Collection(procedure)
Enrollment
1 enrolled
Eligibility
18 years · All sexes
Timeline
2016 – 2018

Study locations (1)

Collaborators

Gilead Sciences

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02928510 on ClinicalTrials.gov

Other trials for Indolent B-cell non-Hodgkin lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Indolent B-cell non-Hodgkin lymphoma →

← Back to all trials